Myopathic syndrome associated with long-term recombinant interferon alfa treatment in 4 patients with skin disorders.
Dippel
E
E
Zouboulis
C C
CC
Tebbe
B
B
Orfanos
C E
CE
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*; D011994:Recombinant Proteins; D012871:Skin Diseases / Q000188:drug therapy*; D013577:Syndrome; D013997:Time Factors
D000970:Antineoplastic Agents; D007370:Interferon Type I; D011994:Recombinant Proteins